Stocks · News reference
Inogen (NASDAQ:INGN) lowers FY2026 sales outlook from $366.000 million-$373.000 million to $355.000 million-$361.000 million vs $369.267 million estimate.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Inogen (NASDAQ:INGN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Filed: 2026-09-30 AccNo: 0001294133-26-000037 Size: 195 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
The health care sector's oversold stocks present buying opportunities for undervalued companies. RSI compares stock strength on up and down days, with an RSI below 30 considered oversold.